Skip to content

Detection and Characterization of Sessile Serrated Lesions (SSL) of the Right Colon

Detection and Characterization of Sessile Serrated Lesions (SSL) of the Right Colon

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02861885
Acronym
Lesion SSL
Enrollment
71
Registered
2016-08-10
Start date
2016-02-24
Completion date
2022-04-24
Last updated
2022-03-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Neoplasm, Sessile Serrated Lesion, Neoplasms

Keywords

Colonoscopy, sessile serrated lesions, chromoendoscopy, narrow band imaging, Indigo Carmin®, Pit pattern, Kudo classification, NICE classification, neoplasms by histologic type

Brief summary

There are a few studies regarding Sessile Serrated Lesions (SSL). They are recently identified as precancerous lesions. Yet, digestive tract serrated lesions would be part of a new colic carcinogenesis way : the serrated tumor way. Evolution from polyp to cancer would be faster than through the usual adenoma to cancer way. It would be then responsible of a lot of missed lesions or interval cancer. The missed SSL rate is estimated at between 27% and 59%. Current diagnosis methods show weakness to identify those SSL. In order to improve their detection, the investigators dispose of several coloration techniques. Indigo carmine chromoendoscopy enhance neoplastic lesion detection as part of the hereditary rectal carcinoma screening. NBI electronic coloration, which is faster and easier has not shown any efficacy on the adenoma detection rate, except for patients with Lynch syndrome. The objective is to better describe the SSL endoscopic semiology (detection and characterization) and to establish standards for the endoscopic techniques in order to improve the colonoscopy diagnosis quality. The investigators propose to evaluate 2 fundamental endoscopic techniques (Narrow Band Imaging (NBI) and indigo carmine), widely used for other indications, in comparison with the White Light technique (WLI). Therefore, the investigators propose a prospective, observational, multicentric cohort study in order to 1) define SSL endoscopic various aspects 2) establish which technique (white light, Narrow Band Imaging, indigo carmine chromoendoscopy) is the best to diagnose SSL, namely detection and characterization 3) evaluate the multifocal dimension rate for those lesions at ascending colon level. The diagnosis impact is immediate, and could allow to consider an update for boh endoscopic NICE and Kudo Pit Pattern classification, and good practice guidances for colonoscopic diagnosis. Better SSL detectability thus their systematic resection could have a long term effect in reducing both colon cancer rate and interval cancer

Interventions

Colonoscopy will run in accordance with standard procedure, including air insufflation throughout the endoscope rise. The endoscope will be a Olympus NBI videoscope (180 series and latest). First, progression will run until caecum without systematic terminal ileum intubation. Polyps will be searched out during descent phase. The patient will be eligible as soon as the operator suspects an ascendant colon SSL with white light. The operator will have to initiate the WLI colonoscopy. If a SSL is suspected in the colon, the operator will run at the same time, a NBI colon examination, then an indigo carmine chromoendoscopy colon examination. Each lesion will be pictured before and after mucus clean-up. Lesions biopsy or resection will be ran in accordance with standard procedure.

Sponsors

Hospices Civils de Lyon
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Male or female patients 18 years of age or older * Patient having an indication for colonoscopy to detect colorectal neoplastic lesions, which meet at least one of the following conditions : * Positive fecal occult blood test * 1st degree family history of colorectal cancer or adenoma before 60 years of age * Personal history of colorectal adenoma or colorectal cancer * Unexplained digestive symptoms after 50 years of age or those not responding to symptomatic treatment : modification of bowel movements, abdominal pains * Isolated or repeated rectal bleeding after 50 years of age or occult bleeding * Acromegaly * Infectious endocarditis with digestive bacteria * Suspicion of sessile serrated lesion in the right colon * None opposite of patient for participating

Exclusion criteria

* History of digestive resection as resection of the right colon (right ileocolectomy, right hemicolectomy) or large colic resection.

Design outcomes

Primary

MeasureTime frameDescription
patients with sessile serrated lesionsat colonoscopy day (Day 1)Proportion of patient for whom at least one new SSL has been shown macroscopically through NBI and/or indigo carmine chromoendoscopy but not detected with WLI

Secondary

MeasureTime frameDescription
Kudo's pit pattern classificationat colonoscopy day (Day 1)All SSL will be characterized using the Kudo's pit pattern classification for colorectal neoplasms
NICE classificationat colonoscopy day (Day 1)All SSL will be characterized using the Narrow band imaging International Colorectal Endoscopic (NICE) of small colorectal polyps.
Specific mean of macroscopically detected SSLat colonoscopy day (Day 1)Comparison of the mean number of SSL per technique (white light, Narrow Band Imaging, indigo carmine chromoendoscopy)
PARIS classificationat colonoscopy day (Day 1)All SSL will be characterized using the PARIS classification of colorectal polyps
False positivehistopathological results (up to 2 weeks)Number of suspected SSL macroscopically but unconfirmed histologically
False negativehistopathological results (up to 2 weeks)Number of polyps not identified as SSL, but reclassified by histological results
Detection techniques diagnosis performanceat colonoscopy day (Day 1)Proportion of macroscopically suspected SSL by one of the 3 techniques (white light, Narrow Band Imaging, indigo carmine chromoendoscopy) and confirmed by centralized review (macro true positive)
SSL histologic characterizationhistopathological results (up to 2 weeks)All SSL will be characterized using the Vienna classification of gastrointestinal epithelial neoplasia

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026